Showing results (41-50 of 352) with videos related to
Sort By:
Pageof 36
International Journal of Technology Assessment in Health Care|October 24, 2002
Preference-based outcome measures in cost-utility analyses. A 20-year overviewDan Greenberg, Joseph S PliskinValue in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 31, 2002
FDA actions against misleading or unsubstantiated economic and quality-of-life promotional claims: an analysis of warning letters and notices of violationKate A Stewart, Peter J NeumannExpert Review of Pharmacoeconomics & Outcomes Research|October 22, 2013
A survey of individuals in US-based pharmaceutical industry HEOR departments: attitudes on policy topicsPeter J Neumann, Cayla J SaretAlzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 18, 2008
Decision analytic models for Alzheimer's disease: state of the art and future directionsJoshua T Cohen, Peter J NeumannValue in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 23, 2015
When Does FDAMA Section 114 Apply? Ten Case StudiesPeter J Neumann, Cayla J SaretPharmacoeconomics|October 28, 2006
Economic evaluation in the US: what is the missing link?Peter J Neumann, Sean D SullivanAmerican Journal of Preventive Medicine|October 31, 2002
Do HEDIS measures reflect cost-effective practices?Peter J Neumann, Bat Sheva LevineFundamental & Clinical Pharmacology|November 30, 2005
Quality-adjusted life years: how useful in medico economic studiesCarmen A Brauer, Peter J NeumannHealth Affairs (Project Hope)|September 11, 2008
Using decision analysis to better evaluate pediatric clinical guidelinesJoshua T Cohen, Peter J NeumannHealth Services Research|August 19, 2009
A framework to measure the value of public health servicesPeter D Jacobson, Peter J NeumannPageof 36